诺诚健华:2023年股东周年大会会议资料
InnoCare Pharma Limited
9969(1)(2)(3)(4)
(5)(6)(7)(8)(9)(10)
(11)
(12)(13)
AGM-1AGM-7( www.hkexnews.hk)( www.innocarepharma.com)
18317M
– i –
...... 1
...... 3
...... 9
1. ......................................................10
2. .........................................10
3. .................................10
4. .................................11
5. ...................................11
6. ..............................................11
7. .......................................12
8. .......................................13
9. ........................13
10. ...............................4811. ...... 48
12. .............50
13. ................52
14. .....................................54
15. ..........................................54
16. ..........................54
17. .......................................55
18. ..........................................55
19. ..............................................55
20. ............................................56
21. ..................................................56
22. ..................................................56
– ii – ...... I-1
...... II-1 ..................................III-1 ...... IV-1
...... V-1
...... VI-1 ..............................VII-1 ...............................................AGM-1
1.
(i)
“” http://meetings.computershare.com/InnocareAGM2023
(ii)
(iii)
(1)
“”(2)
2.
3.
(www.hkexnews.hk)(www.innocarepharma.com)
18317M
18317M
(852) 2862 8555
(852) 2865 0990
www.computershare.com/hk/contact
(www.hkexnews.hk)(www.innocarepharma.com)
“
”
10%10%
“
”“
”
“”
“”“”“”
AGM-1AGM-7“”
“”14A.06(2)“”
“”
“”
“”
9969688428“”“”“”“”“”14A.06(7)“”“”“”
“”“”7,209,000
80.56%
“”
“”“”
“”“”“”“”“”
0.000002
“”
“”
“”
“”
“”
“”
“”“”
Jisong CuiRenbin Zhao
5%
“”
“”
“
”
“”1,739,750
19.44%
“”
“”“”
“”
0.000002
“”“11.
”
“”“”“”
“”
0.000002
“”“”“”“”“”
“”“”“”
1.01
“”
“”
“”“”
“”
“”
“%”
InnoCare Pharma Limited
9969Ogier Global (Cayman) Limited89 Nexus Way, Camana BayGrand Cayman, KY1-9009Cayman Islands
(1)(2)(3)(4)
(5)(6)(7)(8)(9)(10)
(11)(12)(13)
1.AGM-1AGM-7
(1)(2)(3)
(4)(5)
(6)(7)
(8)(9)
(10)
(11)(13)
(12)2.
(http://www.sse.com.cn)(http://www.hkexnews.hk)(www.innocarepharma.com)
(http://www.hkexnews.hk)(http://www.sse.com.cn)(www.innocarepharma.com)3.
4.
5.
20%1,499,673,235264,648,2175
299,934,64752,929,64376520%
10%
6.
114.(a)
7.
(a)
(b) 3.13
(c)
3.13
8.
9.
“(i)”
(i)
30,629,507
1.74%
51,481,607
2.92%
“”
“”8,948,750
0.51%
“11.
”
“”“”
10%10%
“”
3.43%(i)(ii)
20%
10%1%
0.1%
894.875
176,432.14520.51%
720.900
176,432.14520.41%
80.56%173.975
176,432.14520.10%19.44%
1.
2.
5%
1 115
93912.25%(1)(2)
5%
2. 12
0.1%
1.
165.00018.44%0.09%
50.0005.59%0.03% 40.0004.47%0.02%
255.00028.50%0.14%2.112465.90052.06%0.26%
720.90080.56%0.41%3.
173.97519.44%0.10%
894.875100.00%0.51%
1%
0.1%
20%
10%
5%
1.
2. 5
“”
1212
1.
(1)
(2)
2.
1.
2.
3.
4.
25%
25%
25%
25%
25%
25%
25%
25%
1.
25%
2.
6.95
6.95
1. 1
13.5750.00%6.79
2. 20
2020
13.6450.00%6.82
3. 60
6060
13.1650.00%6.58
4. 120
120120
13.8950.00%6.95
1.
(1)
(2)
(3) 36
(4)(5)2.
(1) 12
(2) 12
(3) 12
(4)
(5)(6)
“”
(1)
(2)
(3) 36
(4)(5)
(1) 12
(2) 12
(3) 12
(4)
(5)(6)
ABC
100%80%70%
IIIIII
IIIIII
IIIIII
ABC
100%80%70%
IIIIII
21.5
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
“”
ABC
100%80%70%
IIIIII
21.5
IIIIII
IIIIII
ABC
100%80%70%
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
ABC
100%80%70%
IIIIII
IIIIII
IIIIII
ME & ME AboveME-BE
ME & ME
AboveME-BE
100%80%0
=××
4 6
5%
4 60
1212
(1)
(2)
(1)(2)
×1nQ
nQ
×P
×1n÷P
P
×nQ
P
P
nQ
×nQ
n1nQ
PP
÷1nP
nP
PP
×P
P
×n÷[P
×1n]P
P
P
nP
PP
÷nP
nP
PP
-V
P
VPP1
1122
1122
Black-Scholes
7,209,000
1 13.53
2 12243648
3 31.9489% 34.9121%35.7182%36.3346%
122436484 2.1754%2.4056%2.4887% 2.5758%
1234
7,209,0005,217.511,543.501,936.371,058.37533.97145.31
1.
2.
3.
4.
5.
6.
7.
8.
1.
2.3.
4.
5.
6.
7.
8.
9.
1.
(1)
(2)
(3) 36
(4)(5)2.
(1)(2)
3.
1.
(1) 12
(2) 12
(3) 12
(4)
(5)(6)2.
3.
4.
5.
(1)
(2)
6.
(1)
(2)
7.
10.
11.
8,948,750
0.51%
3.43%(i)(ii)
“9.”
62,193,812.508,948,750
6.95
“VI.”
0.000002
17.8975
(1)264,648,217273,596,9671,499,673,2351,499,673,2351,764,321,4521,773,270,202
(1)
(1)
75.40%75.52%
(1)
264,648,217
2,778.82
1.“”
2.3.4.5.
12.
(1)
(2)
(3)
(4)
(5)
(6)(7)
(8)
(9)
(10)
(11)
(12)
(13)
13.
(i)
(i)121%(ii)
0.1%
3.43%(i)(ii)
(ii)
17.03(13)
17.03(13)
17.03(13)
17.03(13)
(i)
“”“”
(ii)
(iii)8,948,750
1,764,321,4520.51%(iv)
(iii)
8.2013.26
14.
15.
(i)(ii)
16.
17.
183171712-171618.
AGM-1AGM-7
(i)(ii)(iii)
19.
( www.hkexnews.hk)( www.innocarepharma.com)
20.
(i)(ii)(iii)
(iv)
21.
22.
(i)(ii)(iii)
(iv)
(i)
(ii)(iii)
(iv)
(v)“”
(i)(ii)(iii)(iv)
(v)
– I-1 –
20222022“”
2022
2022
2022Tafasitamab13I/II/III1.0
2.0
2022
202213
12022.03.232322022.03.29232022.05.05142022.05.072
– I-2 –
52022.05.11162022.06.01372022.07.20182022.08.08392022.08.192102022.10.124112022.11.112122022.12.071132022.12.231
1 A
277,881.562022
1A
– I-3 –
A
A
– I-4 –
e
20221
2022
20225
20222
20222
– I-5 –
2023
2023
2023426
– II-1 –
13.51(2)
Ph.D.54
ShenzhouTianchen Technology Inc.
?(Johns Hopkins University)
XV116,839,593
Oriza Cowin
– II-2 –
688578
0992602171
XV
Ph.D.77
??“”
?
– II-3 –
??
1349Zai Lab LimitedZLAB
96881801
600557
30,000
XV
3.13
– II-4 –
(i)(ii)(iii)
13.51(2)(h)(v)
– III-1 –
(a)(b) 10.06(1)(b)
(c)
10.06(1)(c)
1,499,673,235264,648,217
10%
149,967,32310%
– III-2 –
– III-3 –
HHLR Advisors, Ltd.208,671,22211.83%HHLR Advisors, Ltd.12.93%
13.9410.00
11.109.56
14.4810.04
14.7810.80
12.4410.36
12.027.86
9.957.20
13.009.00
14.8010.52
15.9013.24
15.428.51
9.507.86
10.907.90
– IV-1 –
A688428 A
09969 B
– IV-2 –
– IV-3 –
(InnoCare Pharma Limited)
“”“”
894.875
176,432.14520.51%
720.900
176,432.14520.41%
80.56%173.975
176,432.14520.10%
19.44%
– IV-4 –
20%10%1%
0.1%
6.95
93912.25%
– IV-5 –
12 12 12
– IV-6 –
– IV-7 –
...... IV-2
...... IV-3
...... IV-8
...... IV-10
...... IV-12
...... IV-13
...... IV-15
...... IV-17
...... IV-22
...... IV-23
...... IV-32
...... IV-36
...... IV-39
...... IV-41
...... IV-43
...... IV-47
– IV-8 –
InnoCare Pharma Limited
– IV-9 –
2023420
(InnoCare Pharma Limited)
– IV-10 –
30,629,507
1.74%
51,481,6072.92%“”
“”“”
10%10%
– IV-11 –
“”,
20%
10%
0.1%
– IV-12 –
– IV-13 –
5%
93912.25%
5%
– IV-14 –
– IV-15 –
894.875
176,432.14520.51%
720.900
176,432.14520.41%80.56%
173.975
176,432.14520.10%19.44%
0.1%
1.
165.00018.44%0.09%
– IV-16 –
50.0005.59%0.03%
40.0004.47%0.02%
255.00028.50%0.14%2. 112
465.90052.06%0.26%
720.90080.56%0.41%3.
173.97519.44%0.10%
894.875100.00%0.51%
1%
120.1%
20%10%2 5%
– IV-17 –
6012
– IV-18 –
– IV-19 –
25%
25%
25%
25%
– IV-20 –
25%
25%
25%
25%
– IV-21 –
25%
– IV-22 –
6.95
6.95
113.57
50.00%6.79
20202013.64
50.00%6.82
60606013.16
50.00%6.58
120120120
13.8950.00%6.95
– IV-23 –
3 36
1 122 123 12
– IV-24 –
“”
3 36
1 122 123 12
– IV-25 –
A100%
B80%
C70%
IIIIII
IIIIII
IIIIII
– IV-26 –
A100%
B80%
C70%
21.5
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
– IV-27 –
A100%
B80%
C70%
IIIIII
IIIIII
IIIIII
“”
– IV-28 –
A100%
B80%
C70%
21.5
IIIIII
IIIIII
IIIIII
– IV-29 –
A100%
B80%
C70%
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
IIIIII
– IV-30 –
A100%
B80%
C70%
IIIIII
IIIIII
IIIIII
– IV-31 –
ME & ME AboveME-BE
ME & MEAboveME-BE
100%80%0=××
– IV-32 –
– IV-33 –
5%
– IV-34 –
– IV-35 –
– IV-36 –
Q = Q
× (1 + n)Q
nQ
Q = Q
× P
×(1 + n)÷ (P
+ P
× n)Q
P
P
nQ
Q = Q
× nQ
n1nQ
– IV-37 –
P = P
÷ (1 + n)P
nP
P = P
× (P
+ P
×n)÷ [P
× (1 + n)]P
P
P
nP
P = P
÷ nP
nP
P = P
– V
P
VPP1
– IV-38 –
– IV-39 –
1122
1122Black-Scholes
720.900
13.53
12243648
31.9489%34.9121%35.7182%36.3346%
12243648 2.1754%2.4056%2.4887%2.5758%1
– IV-40 –
7,209,0005,217.511,543.501,936.371,058.37533.97145.31
– IV-41 –
– IV-42 –
– IV-43 –
3 36
– IV-44 –
1 122 123 12
– IV-45 –
– IV-46 –
– IV-47 –
– V-1 –
“”
“”
“”
(InnoCare Pharma Limited)
– V-2 –
“”
ABC100%80%70%
I-III
I-III
I-III
– V-3 –
ABC100%80%70%
I-III
21.5
I-III
I-III
I-III
I-III
I-III
– V-4 –
ABC100%80%70%
I-III
I-III
I-III
“”
– V-5 –
ABC100%80%70%
I-III
21.5
I-III
I-III
I-III
I-III
I-III
– V-6 –
ABC100%80%70%
I-III
I-III
I-III
I-III
I-III
I-III
– V-7 –
ME &ME AboveME-BE
ME & MEAboveME-BE100%80%0=××
– V-8 –
– VI-1 –
14.14.
1.
0.1%
2.
1.
0.1%
2.
3.
– VI-2 –
– VII-1 –
1(b)
“”
“”
19613
1(b)
“”
“”
19613
– VII-2 –
5(a)5(a)
– VII-3 –
17(d)
17(d)
64(a)64(a)
– VII-4 –
1410
2120
1410
– VII-5 –
84A(a)
(b)
84A
(a)(b)
– VII-6 –
97(b)
97(b)
– VII-7 –
– VII-8 –
186(b)186(b)
– AGM-1 –
InnoCare Pharma Limited
9969
“”
1.
“”“”2.
3. (i)
(ii)(iii)4.“”5.
– AGM-2 –
6.
“(i) (iii)
(v)
“”(ii) (i)
(iii) (i)
(1) (v)(2)
(3)
(4)
– AGM-3 –
20%
“”
(i)(v)(ii)
(iv)
(v)
(a)“”(1)
(2)(i)(ii)
(iii)(b)“”
(1)(2)
(3)“”
– AGM-4 –
(c)“”
”7.
“(i) (ii)
(iv)
“”(ii) (i)
10%(iii) (i)(ii)(i)(ii)
(iv)
“”
(a)
– AGM-5 –
(b)
(c)
”8.
“
10%”9.10.11.12.
13.
14.
15.
16.
– AGM-6 –
17.
– AGM-7 –
(i) 567(ii)(iii)
(iv)
18317M
(v)
183171712-1716(vi) 2
(vii) 5(viii) 6
(ix)(x)